Healthy Volunteers, Pulmonary Arterial Hypertension study: LTP
Official title A Study to Learn About the Treatment LTP001 in Healthy Participants (Part A) and in Participants With PAH (Part B)
ClinicalTrials.gov ID: NCT06649110
What this study is testing
What is LTP?
LTP is an investigational medicine, being studied as a potential treatment for healthy volunteers, pulmonary arterial hypertension.
Plain-language explanation of the investigational treatment. It is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- The study aims to gather safety and early effect information about LTP001 in healthy people and in those with pulmonary arterial hypertension.
- Who it's for
- Adults who are healthy or have pulmonary arterial hypertension.
- What's involved
- Participants will receive LTP001 and undergo study visits and tests.
- Phase 2: a mid-size study of how well it works
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 100. Healthy volunteers may be eligible.
You may be able to join if
- Part A
- Healthy males and non-child-bearing potential females Part A
You likely can't join if
- Clinically significant ECG or cardiac abnormalities, any surgical or medical condition which might significantly alter the absorption, distribution...
- For Japanese cohorts: participants per protocol should be first generation Japanese or up to third generation Japanese as defined in inclusion...
The study team makes the final eligibility decision.
Where it is enrolling
- Scottsdale, Arizona, United States
- Orange, California, United States
- Stanford, California, United States
- Aurora, Colorado, United States
- Orlando, Florida, United States
- Tampa, Florida, United States
- Atlanta, Georgia, United States
- Kansas City, Kansas, United States
- Louisville, Kentucky, United States
- Boston, Massachusetts, United States
- Burlington, Massachusetts, United States
- Ridgeland, Mississippi, United States
- Bend, Oregon, United States
- Pittsburgh, Pennsylvania, United States
- Knoxville, Tennessee, United States
- Austin, Texas, United States
- Dallas, Texas, United States
- Salt Lake City, Utah, United States
- Richmond, Virginia, United States
- Buenos Aires, Buenos Aires F.D., Argentina
+ 62 more site(s).
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 100 years. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
This study is enrolling now at Scottsdale, Arizona, United States; Orange, California, United States; Stanford, California, United States; Aurora, Colorado, United States; Orlando, Florida, United States; Tampa, Florida, United States and 76 more locations. Enter your location above to see the nearest enrolling site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.